Bio-Techne Corporation logo
TECHBio-Techne Corporation

Free Cash Flow Yield: 2.42%

popular:market cap|pe ratio|revenue|price history|total return

Is the free cash flow yield high or low?

The free cash flow yield of 2.42% is 14% above its 5-year average of 2.13%, around the middle of its 5-year range (1.12%–3.97%).

As of Saturday, June 27, 2026. 7.20% below its 12-month average of 2.61%.

Free Cash Flow CAGR|Earnings Yield|Dividend Yield|P/FCF Ratio|All Metrics
TECH Free Cash Flow Yield

TECH Free Cash Flow Yield Chart

2.42%
-7.98% 1Y
TECH Free Cash Flow Yield

TECH Average Free Cash Flow Yield Chart

TECH Free Cash Flow Yield

TECH Current vs Average Free Cash Flow Yield Chart

TECH Free Cash Flow Yield Metrics

FREE CASH FLOW YIELD

2.42%

FREE CASH FLOW YIELD AVG TTM

2.61%

FREE CASH FLOW YIELD AVG 3Y

2.30%

FREE CASH FLOW YIELD AVG 5Y

2.08%

FREE CASH FLOW YIELD AVG 10Y

2.19%

FREE CASH FLOW YIELD AVG 15Y

2.77%

FREE CASH FLOW YIELD AVG 20Y

3.08%

CURRENT VS TTM AVG

-7.20%

CURRENT VS 3Y AVG

+5.39%

CURRENT VS 5Y AVG

+16.58%

CURRENT VS 10Y AVG

+10.33%

CURRENT VS 15Y AVG

-12.58%

CURRENT VS 20Y AVG

-21.52%

TECH Competitors' Free Cash Flow Yield

NAMEMARKET CAPFREE CASH FLOW YIELDTTM3Y5Y
Bio-Techne Corporation (TECH)$11.12B2.42%2.61%2.30%2.08%
Insulet Corp. (PODD)vs ›$10.96B3.71%2.24%1.64%1.64%
Baxter International Inc. (BAX)vs ›$11.38B6.29%3.38%3.96%3.77%
Molina Healthcare, Inc. (MOH)vs ›$11.79B2.28%3.77%4.41%7.08%
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37B5.60%5.84%5.45%8.51%
Charles River Laboratories International, Inc. (CRL)vs ›$10.20B3.76%6.19%5.05%4.16%
Tempus AI, Inc. (TEM)vs ›$9.80BN/A-3.09%-3.23%-3.23%
Henry Schein, Inc. (HSIC)vs ›$9.68B4.37%4.90%5.14%5.37%
Revvity, Inc. (RVTY)vs ›$12.61B3.91%4.58%3.06%4.00%
Align Technology, Inc. (ALGN)vs ›$12.78B5.45%5.44%3.81%3.08%

Yield Comparison

FCF Yield

2.42%

Earnings Yield

0.97%

Dividend Yield

0.45%

Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100

How FCF Yield is used:

  • Shows free cash flow after capital expenditures relative to market cap
  • Can be compared with earnings yield and dividend yield
  • Can be compared with the company's historical range
  • Can be compared with peers that report positive free cash flow

FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.

Free Cash Flow Yield Formula & Definition

FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Free Cash Flow Yield FAQ

What is the free cash flow yield for Bio-Techne Corporation (TECH)?
The free cash flow yield for TECH stock is 2.42%.
Is Bio-Techne Corporation's free cash flow yield high or low?
The free cash flow yield of 2.42% is 14% above its 5-year average of 2.13%, around the middle of its 5-year range (1.12%–3.97%).
What is the TTM average free cash flow yield for Bio-Techne Corporation (TECH)?
The TTM average free cash flow yield for TECH stock is 2.61%.
What is the 3Y average free cash flow yield for Bio-Techne Corporation (TECH)?
The 3Y average free cash flow yield for TECH stock is 2.30%.
What is the 5Y average free cash flow yield for Bio-Techne Corporation (TECH)?
The 5Y average free cash flow yield for TECH stock is 2.08%.
What is the 10Y average free cash flow yield for Bio-Techne Corporation (TECH)?
The 10Y average free cash flow yield for TECH stock is 2.19%.
What is the 15Y average free cash flow yield for Bio-Techne Corporation (TECH)?
The 15Y average free cash flow yield for TECH stock is 2.77%.
What is the 20Y average free cash flow yield for Bio-Techne Corporation (TECH)?
The 20Y average free cash flow yield for TECH stock is 3.08%.

TECH Free Cash Flow Yield History

DATEFREE CASH FLOW YIELD
2026-06-262.42%
2026-06-252.43%
2026-06-242.92%
2026-06-233.05%
2026-06-223.09%
2026-06-182.96%
2026-06-173.12%
2026-06-163.07%
2026-06-153.06%
2026-06-123.18%
2026-06-113.18%
2026-06-103.27%
2026-06-093.16%
2026-06-083.26%
2026-06-053.30%
2026-06-043.23%
2026-06-033.38%
2026-06-023.45%
2026-06-013.38%
2026-05-293.32%
2026-05-283.38%
2026-05-273.57%
2026-05-263.58%
2026-05-223.56%
2026-05-213.63%
2026-05-203.68%
2026-05-193.78%
2026-05-183.87%
2026-05-153.97%
2026-05-143.84%
2026-05-133.83%
2026-05-123.62%
2026-05-113.62%
2026-05-083.55%
2026-05-073.37%
2026-05-063.62%
2026-05-052.51%
2026-05-042.59%
2026-05-012.58%
2026-04-302.57%
2026-04-292.73%
2026-04-282.65%
2026-04-272.58%
2026-04-242.62%
2026-04-232.72%
2026-04-222.42%
2026-04-212.38%
2026-04-202.34%
2026-04-172.40%
2026-04-162.48%
2026-04-152.43%
2026-04-142.42%
2026-04-132.47%
2026-04-102.56%
2026-04-092.56%
2026-04-082.57%
2026-04-072.64%
2026-04-062.64%
2026-04-022.67%
2026-04-012.66%
2026-03-312.72%
2026-03-302.73%
2026-03-272.79%
2026-03-262.70%
2026-03-252.70%
2026-03-242.71%
2026-03-232.73%
2026-03-202.76%
2026-03-192.75%
2026-03-182.80%
2026-03-172.78%
2026-03-162.91%
2026-03-132.79%
2026-03-122.76%
2026-03-112.65%
2026-03-102.69%
2026-03-092.59%
2026-03-062.64%
2026-03-052.54%
2026-03-042.46%
2026-03-032.49%
2026-03-022.46%
2026-02-272.41%
2026-02-262.45%
2026-02-252.45%
2026-02-242.47%
2026-02-232.59%
2026-02-202.47%
2026-02-192.44%
2026-02-182.39%
2026-02-172.43%
2026-02-132.37%
2026-02-122.39%
2026-02-112.24%
2026-02-102.19%
2026-02-092.17%
2026-02-062.13%
2026-02-052.16%
2026-02-042.07%
2026-02-032.22%
2026-02-022.20%
2026-01-302.24%
2026-01-292.24%
2026-01-282.19%
2026-01-272.10%
2026-01-262.12%
2026-01-232.10%
2026-01-222.06%
2026-01-212.01%
2026-01-202.06%
2026-01-162.09%
2026-01-152.05%
2026-01-142.10%
2026-01-132.16%
2026-01-122.15%
2026-01-092.18%
2026-01-082.22%
2026-01-072.20%
2026-01-062.19%
2026-01-052.27%
2026-01-022.40%
2025-12-312.44%
2025-12-302.42%
2025-12-292.42%
2025-12-262.42%
2025-12-242.42%
2025-12-232.42%
2025-12-222.43%
2025-12-192.46%
2025-12-182.51%
2025-12-172.51%
2025-12-162.49%
2025-12-152.44%
2025-12-122.45%
2025-12-112.38%
2025-12-102.36%
2025-12-092.44%
2025-12-082.38%
2025-12-052.32%
2025-12-042.26%
2025-12-032.25%
2025-12-022.28%
2025-12-012.25%
2025-11-282.22%
2025-11-262.22%
2025-11-252.18%
2025-11-242.26%
2025-11-212.33%
2025-11-202.44%
2025-11-192.48%
2025-11-182.46%
2025-11-172.44%
2025-11-142.41%
2025-11-132.36%
2025-11-122.33%
2025-11-112.42%
2025-11-102.49%
2025-11-072.50%
2025-11-062.46%
2025-11-052.39%
2025-11-042.70%
2025-11-032.69%
2025-10-312.63%
2025-10-302.70%
2025-10-292.66%
2025-10-282.58%
2025-10-272.56%
2025-10-242.50%
2025-10-232.49%
2025-10-222.58%
2025-10-212.60%
2025-10-202.63%
2025-10-172.66%
2025-10-162.67%
2025-10-152.76%
2025-10-142.78%
2025-10-132.76%
2025-10-102.81%
2025-10-092.75%
2025-10-082.72%
2025-10-072.78%
2025-10-062.66%
2025-10-032.62%
2025-10-022.65%
2025-10-012.75%
2025-09-302.96%
2025-09-293.15%
2025-09-263.18%
2025-09-253.26%
2025-09-243.22%
2025-09-233.11%
2025-09-223.11%
2025-09-193.10%
2025-09-183.11%
2025-09-173.20%
2025-09-163.18%
2025-09-153.19%
2025-09-123.21%
2025-09-113.10%
2025-09-103.23%
2025-09-093.04%
2025-09-083.04%
2025-09-053.03%
2025-09-043.11%
2025-09-033.09%
2025-09-023.08%
2025-08-293.01%
2025-08-283.03%
2025-08-272.93%
2025-08-262.90%
2025-08-252.90%
2025-08-222.89%
2025-08-212.57%
2025-08-202.56%
2025-08-192.53%
2025-08-182.61%
2025-08-152.59%
2025-08-142.58%
2025-08-132.54%
2025-08-122.63%
2025-08-112.77%
2025-08-082.75%
2025-08-072.77%
2025-08-062.78%
2025-08-052.54%
2025-08-042.53%
2025-08-012.53%
2025-07-312.54%
2025-07-302.41%
2025-07-292.40%
2025-07-282.37%
2025-07-252.36%
2025-07-242.38%
2025-07-232.51%
2025-07-222.61%
2025-07-212.76%
2025-07-182.67%
2025-07-172.61%
2025-07-162.68%
2025-07-152.70%
2025-07-142.64%
2025-07-112.57%
2025-07-102.55%
2025-07-092.64%
2025-07-082.64%
2025-07-072.69%
2025-07-032.61%
2025-07-022.61%
2025-07-012.67%
2025-06-302.70%
2025-06-272.68%
2025-06-262.63%
2025-06-252.68%
2025-06-242.78%
2025-06-232.82%
2025-06-202.78%
2025-06-182.77%
2025-06-172.81%
2025-06-162.69%
2025-06-132.75%

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

Related Metrics

Free Cash Flow CAGREarnings YieldDividend YieldP/FCF RatioAll Metrics

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Minneapolis, MN
3,100 employees
www.bio-techne.com
Healthcare / Biotechnology
Sector
Healthcare
Industry
Biotechnology
CEO
Kim Kelderman
View full financials